{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:24:04Z","timestamp":1794432244299,"version":"4.9.1"},"reference-count":144,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:p>Vaccines administered to women during pregnancy can provide protection against serious infectious diseases for the mother, the child, or both. Maternal immunization boosts the concentration of maternal antibodies that can be transferred across the placenta to directly protect children too young to be immunized. In addition, indirect protection through prevention of maternal infection and breast-milk antibodies can be achieved through maternal immunization. In general, inactivated vaccines are considered safe for pregnant women and fetuses, whereas live attenuated vaccines are avoided due to the theoretical potential risk of infection to the fetus. However, the potential risks of vaccines need to be weighed against the risk of the disease itself and the benefits of vaccination in terms of protection of the mother and child against infectious disease. Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap); influenza; coronavirus disease 2019 (COVID-19); and respiratory syncytial virus (RSV) vaccines are routinely recommended for all pregnant women in the United States. Maternal immunization has the potential to improve the health of mothers and young children; therefore, other diseases of relevance during this period are now targets of active research and vaccine development, including group B streptococcus (GBS). Similarly, several vaccines can be administered during pregnancy in special circumstances when maternal health, travel, or other special situations arise. This article reviews the current recommendations for vaccination of women during pregnancy.<\/jats:p>","DOI":"10.1097\/aog.0000000000006243","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T22:00:34Z","timestamp":1771538434000},"page":"661-678","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Maternal Immunization"],"prefix":"10.1097","volume":"147","author":[{"given":"Denise J.","family":"Jamieson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flor M.","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja A.","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"R1-20261111","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.acap.2024.06.019","article-title":"Reflections on the Advisory Committee on Immunization Practices during the COVID-19 pandemic","volume":"24","author":"Poehling","year":"2024","journal-title":"Acad Pediatr"},{"key":"R3-20261111","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMra1213566","article-title":"Pregnancy and infection","volume":"370","author":"Kourtis","year":"2014","journal-title":"N Engl J Med"},{"key":"R4-20261111","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJMra1509044","article-title":"Maternal immunization","volume":"376","author":"Omer","year":"2017","journal-title":"N Engl J Med"},{"key":"R5-20261111","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/AOG.0000000000000857","article-title":"Risks associated with smallpox vaccination in pregnancy: a systematic review and meta-analysis","volume":"125","author":"Badell","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R6-20261111","doi-asserted-by":"crossref","first-page":"e2022057627","DOI":"10.1542\/peds.2022-057627","article-title":"Congenital Rubella syndrome following Rubella vaccination during pregnancy","volume":"152","author":"Bouthry","year":"2023","journal-title":"Pediatrics"},{"key":"R7-20261111","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1093\/infdis\/168.6.1520","article-title":"Congenital yellow fever virus infection after immunization in pregnancy","volume":"168","author":"Tsai","year":"1993","journal-title":"J Infect Dis"},{"key":"R8-20261111","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/AOG.0000000000000533","article-title":"What obstetrician-gynecologists should know about Ebola: a perspective from the Centers for Disease Control and Prevention","volume":"124","author":"Jamieson","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R9-20261111","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/GRF.0000000000000332","article-title":"Ebola infection in pregnancy: a global perspective and lessons learned","volume":"61","author":"Haddad","year":"2018","journal-title":"Clin Obstet Gynecol"},{"key":"R10-20261111","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ajog.2012.07.011","article-title":"The safety of adjuvants in influenza vaccines during pregnancy: what do we know and why do we need them?","volume":"207","author":"Jamieson","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"R11-20261111","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.vaccine.2009.11.077","article-title":"Exposure to MF59-adjuvanted influenza vaccines during pregnancy\u2014a retrospective analysis","volume":"28","author":"Tsai","year":"2010","journal-title":"Vaccine"},{"key":"R12-20261111","doi-asserted-by":"crossref","first-page":"177.e1","DOI":"10.1016\/j.ajog.2012.07.007","article-title":"Safety of MF59-adjuvanted A\/H1N1 influenza vaccine in pregnancy: a comparative cohort study","volume":"207","author":"Heikkinen","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"R13-20261111","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/j.vaccine.2015.03.041","article-title":"A\/H1N1 pandemic influenza vaccination: a retrospective evaluation of adverse maternal, fetal and neonatal outcomes in a cohort of pregnant women in Italy","volume":"33","author":"Fabiani","year":"2015","journal-title":"Vaccine"},{"key":"R14-20261111","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1016\/j.vaccine.2015.07.035","article-title":"Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)","volume":"33","author":"Shimabukuro","year":"2015","journal-title":"Vaccine"},{"issue":"suppl 1","key":"R15-20261111","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1542\/peds.2010-1722H","article-title":"The Vaccine Safety Datalink: a model for monitoring immunization safety","volume":"127","author":"Baggs","year":"2011","journal-title":"Pediatrics"},{"key":"R16-20261111","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/j.whi.2012.10.003","article-title":"Enrolling pregnant women: issues in clinical research","volume":"23","author":"Blehar","year":"2013","journal-title":"Womens Health Issues"},{"key":"R17-20261111","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.ajog.2011.01.047","article-title":"Safety of influenza immunizations and treatment during pregnancy: the Vaccines and Medications in Pregnancy Surveillance System","volume":"204","author":"Schatz","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"suppl 1","key":"R18-20261111","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1542\/peds.2010-1722J","article-title":"Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network","volume":"127","author":"LaRussa","year":"2011","journal-title":"Pediatrics"},{"key":"R19-20261111","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1056\/NEJMoa2104983","article-title":"Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons","volume":"384","author":"Shimabukuro","year":"2021","journal-title":"N Engl J Med"},{"issue":"suppl 3","key":"R21-20261111","doi-asserted-by":"crossref","first-page":"125748","DOI":"10.1016\/j.vaccine.2024.02.065","article-title":"Overview of U.S. COVID-19 vaccine safety surveillance systems","volume":"42","author":"Gee","year":"2024","journal-title":"Vaccine"},{"key":"R22-20261111","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMsa2514268","article-title":"Updated evidence for Covid-19, RSV, and influenza vaccines for 2025-2026","volume":"393","author":"Scott","year":"2025","journal-title":"N Engl J Med"},{"key":"R23-20261111","first-page":"CD001269","article-title":"Vaccines for preventing influenza in healthy adults","volume":"2","author":"Demicheli","year":"2018","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R24-20261111","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S1473-3099(17)30252-9","article-title":"Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial","volume":"17","author":"Steinhoff","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"R25-20261111","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1093\/cid\/ciy737","article-title":"Influenza vaccine effectiveness in preventing influenza-associated hospitalizations during pregnancy: a multi-country retrospective test negative design study, 2010-2016","volume":"68","author":"Thompson","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R26-20261111","doi-asserted-by":"crossref","first-page":"127483","DOI":"10.1016\/j.vaccine.2025.127483","article-title":"Effectiveness of 2023-2024 seasonal influenza vaccine against influenza-associated emergency department and urgent care encounters among pregnant and non-pregnant women of reproductive age","volume":"62","author":"Reeves","year":"2025","journal-title":"Vaccine"},{"key":"R27-20261111","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1056\/NEJMoa0708630","article-title":"Effectiveness of maternal influenza immunization in mothers and infants","volume":"359","author":"Zaman","year":"2008","journal-title":"N Engl J Med"},{"key":"R28-20261111","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJMoa1401480","article-title":"Influenza vaccination of pregnant women and protection of their infants","volume":"371","author":"Madhi","year":"2014","journal-title":"N Engl J Med"},{"key":"R29-20261111","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S1473-3099(16)30054-8","article-title":"Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial","volume":"16","author":"Tapia","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"R30-20261111","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1016\/j.ajog.2011.02.042","article-title":"Impact of maternal immunization on influenza hospitalizations in infants","volume":"204","author":"Poehling","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"R31-20261111","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1055\/s-2004-831888","article-title":"Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants","volume":"21","author":"Black","year":"2004","journal-title":"Am J Perinatol"},{"key":"R32-20261111","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1001\/archpedi.160.12.1277","article-title":"Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants","volume":"160","author":"France","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R33-20261111","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1086\/657309","article-title":"Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants","volume":"51","author":"Benowitz","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R34-20261111","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1001\/archpediatrics.2010.192","article-title":"Maternal influenza vaccination and effect on influenza virus infection in young infants","volume":"165","author":"Eick","year":"2011","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R35-20261111","doi-asserted-by":"crossref","first-page":"20959","DOI":"10.2807\/1560-7917.ES2014.19.45.20959","article-title":"Effectiveness of seasonal influenza vaccination during pregnancy in preventing influenza infection in infants, England, 2013\/14","volume":"19","author":"Dabrera","year":"2014","journal-title":"Euro Surveill"},{"key":"R36-20261111","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/INF.0000000000001258","article-title":"Effect of maternal influenza vaccination on hospitalization for respiratory infections in newborns: a retrospective cohort study","volume":"35","author":"Regan","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R37-20261111","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/jamapediatrics.2023.5639","article-title":"Maternal vaccine effectiveness against influenza-associated hospitalizations and emergency department visits in infants","volume":"178","author":"Sahni","year":"2024","journal-title":"JAMA Pediatr"},{"key":"R38-20261111","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/INF.0000000000001914","article-title":"Maternal influenza immunization and prevention of severe clinical pneumonia in young infants: analysis of randomized controlled trials conducted in Nepal, Mali and South Africa","volume":"37","author":"Omer","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"R39-20261111","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jamapediatrics.2016.0921","article-title":"Duration of infant protection against influenza illness conferred by maternal immunization: secondary analysis of a randomized clinical trial","volume":"170","author":"Nunes","year":"2016","journal-title":"JAMA Pediatr"},{"key":"R40-20261111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6505a1","article-title":"Prevention and control of seasonal influenza with vaccines","volume":"65","author":"Grohskopf","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"R41-20261111","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1586\/erv.12.72","article-title":"Safety of seasonal influenza and influenza A (H1N1) 2009 monovalent vaccines in pregnancy","volume":"11","author":"Moro","year":"2012","journal-title":"Expert Rev Vaccin"},{"key":"R42-20261111","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1016\/j.vaccine.2017.06.069","article-title":"Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12","volume":"35","author":"Donahue","year":"2017","journal-title":"Vaccine"},{"key":"R43-20261111","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1016\/j.vaccine.2019.09.035","article-title":"Inactivated influenza vaccine and spontaneous abortion in the Vaccine Safety Datalink in 2012-13, 2013-14, and 2014-15","volume":"37","author":"Donahue","year":"2019","journal-title":"Vaccine"},{"key":"R44-20261111","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/AOG.0000000000002573","article-title":"Influenza vaccination, pregnancy safety, and risk of early pregnancy loss","volume":"131","author":"Sperling","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R45-20261111","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/GRF.0b013e31824f3b38","article-title":"Prevention of pertussis, tetanus, and diphtheria among pregnant, postpartum women, and infants","volume":"55","author":"Gall","year":"2012","journal-title":"Clin Obstet Gynecol"},{"key":"R46-20261111","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1086\/421033","article-title":"Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum","volume":"190","author":"Healy","year":"2004","journal-title":"J Infect Dis"},{"key":"R47-20261111","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Broder","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"R48-20261111","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel","volume":"55","author":"Kretsinger","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"R49-20261111","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/INF.0000000000000486","article-title":"Evaluation of the impact of a pertussis cocooning program on infant pertussis infection","volume":"34","author":"Healy","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"R50-20261111","first-page":"13","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R51-20261111","first-page":"131","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women\u2014Advisory Committee on Immunization Practices (ACIP), 2012","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R52-20261111","doi-asserted-by":"crossref","first-page":"77","DOI":"10.15585\/mmwr.mm6903a5","article-title":"Use of tetanus Toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: updated recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2019","volume":"69","author":"Havers","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R53-20261111","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/AOG.0000000000001888","article-title":"Safety of Tetanus, diphtheria, and pertussis vaccination during pregnancy: a systematic review","volume":"129","author":"McMillan","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R54-20261111","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S1473-3099(22)00749-6","article-title":"US approval of Tdap vaccine specifically in pregnancy","volume":"22","author":"Venkatesan","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"R55-20261111","doi-asserted-by":"crossref","first-page":"ofae655","DOI":"10.1093\/ofid\/ofae655","article-title":"Impact of the US maternal tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccination program on preventing pertussis in infants 2 to <6 months of age: a case-control evaluation","volume":"11","author":"Skoff","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"R56-20261111","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1097\/INF.0000000000004598","article-title":"Pertussis vaccination during pregnancy: regional situation and impact of implementation on national immunization programs in Latin America","volume":"44","author":"Gentile","year":"2025","journal-title":"Pediatr Infect Dis J"},{"key":"R57-20261111","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1093\/cid\/cix724","article-title":"Impact of the US maternal tetanus, diphtheria, and acellular pertussis vaccination program on preventing pertussis in infants <2 months of age: a case-control evaluation","volume":"65","author":"Skoff","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R58-20261111","doi-asserted-by":"crossref","first-page":"e20164091","DOI":"10.1542\/peds.2016-4091","article-title":"Effectiveness of vaccination during pregnancy to prevent infant pertussis","volume":"139","author":"Baxter","year":"2017","journal-title":"Pediatrics"},{"key":"R59-20261111","doi-asserted-by":"crossref","first-page":"g4219","DOI":"10.1136\/bmj.g4219","article-title":"Safety of pertussis vaccination in pregnant women in UK: observational study","volume":"349","author":"Donegan","year":"2014","journal-title":"BMJ"},{"key":"R60-20261111","doi-asserted-by":"crossref","first-page":"59.e1","DOI":"10.1016\/j.ajog.2012.05.006","article-title":"Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women","volume":"207","author":"Zheteyeva","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"R61-20261111","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/AOG.0000000000000862","article-title":"Pregnancy outcomes after antepartum tetanus, diphtheria, and acellular pertussis vaccination","volume":"125","author":"Morgan","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R62-20261111","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.jpeds.2013.06.021","article-title":"Tetanus, diphtheria, acellular pertussis vaccine during pregnancy: pregnancy and infant health outcomes","volume":"163","author":"Shakib","year":"2013","journal-title":"J Pediatr"},{"key":"R63-20261111","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1001\/jama.2014.14825","article-title":"Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes","volume":"312","author":"Kharbanda","year":"2014","journal-title":"JAMA"},{"key":"R64-20261111","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1016\/j.vaccine.2017.05.041","article-title":"Maternal Tdap vaccination and risk of infant morbidity","volume":"35","author":"DeSilva","year":"2017","journal-title":"Vaccine"},{"key":"R65-20261111","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1016\/j.vaccine.2017.06.071","article-title":"Prenatal Tdap immunization and risk of maternal and newborn adverse events","volume":"35","author":"Layton","year":"2017","journal-title":"Vaccine"},{"key":"R66-20261111","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1016\/j.vaccine.2023.04.043","article-title":"Tdap vaccination during pregnancy and risk of chorioamnionitis and related infant outcomes","volume":"41","author":"Greenberg","year":"2023","journal-title":"Vaccine"},{"key":"R67-20261111","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.cmi.2025.03.014","article-title":"Safety of pertussis vaccination in pregnancy and effectiveness in infants: a Danish national cohort study 2019-2023","volume":"31","author":"Kildegaard","year":"2025","journal-title":"Clin Microbiol Infect"},{"key":"R68-20261111","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/cid\/ciw027","article-title":"Maternal immunization earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussis","volume":"62","author":"Eberhardt","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R69-20261111","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1016\/j.vaccine.2014.08.038","article-title":"The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels - a prospective study","volume":"32","author":"Abu Raya","year":"2014","journal-title":"Vaccine"},{"key":"R70-20261111","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1001\/jama.2014.3633","article-title":"Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial","volume":"311","author":"Munoz","year":"2014","journal-title":"JAMA"},{"key":"R71-20261111","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.vaccine.2015.10.100","article-title":"Pertussis vaccination during pregnancy in Belgium: results of a prospective controlled cohort study","volume":"34","author":"Maertens","year":"2016","journal-title":"Vaccine"},{"key":"R72-20261111","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.vaccine.2015.10.098","article-title":"Pertussis vaccination during pregnancy in Vietnam: results of a randomized controlled trial pertussis vaccination during pregnancy","volume":"34","author":"Hoang","year":"2016","journal-title":"Vaccine"},{"key":"R73-20261111","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.3390\/vaccines12121346","article-title":"Epidemiology of pertussis after the COVID-19 pandemic: analysis of the factors involved in the resurgence of the disease in high-middle-and low-income countries","volume":"12","author":"Bricks","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"R74-20261111","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3390\/vaccines12091030","article-title":"Pertussis epidemiology in children: the role of maternal immunization","volume":"12","author":"Principi","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"R75-20261111","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.15585\/mmwr.mm6944e3","article-title":"Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status\u2014United States, January 22-October 3, 2020","volume":"69","author":"Zambrano","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R76-20261111","doi-asserted-by":"crossref","first-page":"429","DOI":"10.15585\/mmwr.mm7111e2","article-title":"Hospitalization of infants and children aged 0-4 years with laboratory-confirmed COVID-19\u2014COVID-NET, 14 States, March 2020-February 2022","volume":"71","author":"Marks","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R77-20261111","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2204399","article-title":"Maternal vaccination and risk of hospitalization for Covid-19 among infants","volume":"387","author":"Halasa","year":"2022","journal-title":"N Engl J Med"},{"key":"R78-20261111","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s40264-024-01458-w","article-title":"Safety and effectiveness of COVID-19 vaccines during pregnancy: a living systematic review and meta-analysis","volume":"47","author":"Ciapponi","year":"2024","journal-title":"Drug Saf"},{"issue":"suppl 2","key":"R79-20261111","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1093\/infdis\/jiac120","article-title":"Respiratory syncytial virus is the leading cause of United States infant hospitalizations, 2009-2019: a study of the national (Nationwide) inpatient sample","volume":"226","author":"Suh","year":"2022","journal-title":"J Infect Dis"},{"key":"R80-20261111","doi-asserted-by":"crossref","first-page":"e341","DOI":"10.1542\/peds.2013-0303","article-title":"Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age","volume":"132","author":"Hall","year":"2013","journal-title":"Pediatrics"},{"key":"R81-20261111","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMoa0804877","article-title":"The burden of respiratory syncytial virus infection in young children","volume":"360","author":"Hall","year":"2009","journal-title":"N Engl J Med"},{"key":"R82-20261111","doi-asserted-by":"crossref","first-page":"273","DOI":"10.15585\/mmwr.mm7416a1","article-title":"Interim evaluation of respiratory syncytial virus hospitalization rates among infants and young children after introduction of respiratory syncytial virus prevention products\u2014United States, October 2024-February 2025","volume":"74","author":"Patton","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R83-20261111","doi-asserted-by":"crossref","first-page":"508","DOI":"10.15585\/mmwr.mm7432a3","article-title":"Use of clesrovimab for prevention of severe respiratory syncytial virus-associated lower respiratory tract infections in infants: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2025","volume":"74","author":"Moulia","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R84-20261111","doi-asserted-by":"crossref","first-page":"920","DOI":"10.15585\/mmwr.mm7234a4","article-title":"Use of nirsevimab for the prevention of respiratory syncytial virus disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2023","volume":"72","author":"Jones","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R85-20261111","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1097\/AOG.0000000000005492","article-title":"Obstetricians need to know about respiratory syncytial virus","volume":"143","author":"Debessai","year":"2024","journal-title":"Obstet Gynecol"},{"key":"R86-20261111","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S2352-4642(25)00155-5","article-title":"Bivalent prefusion F vaccination in pregnancy and respiratory syncytial virus hospitalisation in infants in the UK: results of a multicentre, test-negative, case-control study","volume":"9","author":"Williams","year":"2025","journal-title":"Lancet Child Adolesc Health"},{"key":"R87-20261111","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa2305478","article-title":"RSV prefusion F protein-based maternal vaccine\u2014preterm birth and other outcomes","volume":"390","author":"Dieussaert","year":"2024","journal-title":"N Engl J Med"},{"key":"R88-20261111","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/AOG.0000000000005817","article-title":"Preterm birth frequency and associated outcomes from the MATISSE (maternal immunization study for safety and efficacy) maternal trial of the bivalent respiratory syncytial virus prefusion F protein vaccine","volume":"145","author":"Madhi","year":"2025","journal-title":"Obstet Gynecol"},{"key":"R89-20261111","doi-asserted-by":"crossref","first-page":"e2419268","DOI":"10.1001\/jamanetworkopen.2024.19268","article-title":"Nonadjuvanted bivalent respiratory syncytial virus vaccination and perinatal outcomes","volume":"7","author":"Son","year":"2024","journal-title":"JAMA Netw Open"},{"key":"R90-20261111","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/AOG.0000000000006121","article-title":"Maternal and neonatal outcomes after respiratory syncytial virus prefusion F protein vaccination during pregnancy: analysis from the 2024-2025 immunization campaign in France","volume":"147","author":"Gabet","year":"2026","journal-title":"Obstet Gynecol"},{"key":"R91-20261111","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/AOG.0000000000006130","article-title":"Maternal respiratory syncytial virus vaccination and preterm birth: a Utah statewide retrospective cohort study","volume":"147","author":"Solsman","year":"2026","journal-title":"Obstet Gynecol"},{"key":"R94-20261111","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1055\/a-2505-5434","article-title":"Pneumonia vaccines: indications for use and current safety data in pregnancy","volume":"42","author":"Dutra","year":"2025","journal-title":"Am J Perinatol"},{"key":"R95-20261111","first-page":"CD004903","article-title":"Pneumococcal vaccination during pregnancy for preventing infant infection","volume":"1","author":"Chaithongwongwatthana","year":"2015","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R96-20261111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6909a1","article-title":"Meningococcal vaccination: recommendations of the Advisory Committee on Immunization Practices, United States, 2020","volume":"69","author":"Mbaeyi","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"R98-20261111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6905a1","article-title":"Prevention of hepatitis A virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices, 2020","volume":"69","author":"Nelson","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"R99-20261111","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/AOG.0000000000005300","article-title":"Viral hepatitis in pregnancy. ACOG Clinical Practice Guideline No. 6. American College of Obstetricians and Gynecologists","volume":"142","year":"2023","journal-title":"Obstet Gynecol"},{"key":"R101-20261111","first-page":"298","article-title":"AAP continues recommending birth dose of hepatitis B vaccine after ACIP's vote to remove","volume":"335","author":"Anderer","year":"2026","journal-title":"JAMA"},{"key":"R102-20261111","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1053\/j.gastro.2024.06.014","article-title":"AGA clinical practice update on pregnancy-related gastrointestinal and liver disease: expert review","volume":"167","author":"Kothari","year":"2024","journal-title":"Gastroenterology"},{"key":"R103-20261111","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2023.12.023","article-title":"Society for Maternal-Fetal Medicine Consult Series #69: hepatitis B in pregnancy: updated guidelines","volume":"230","author":"Badell","year":"2024","journal-title":"Am J Obstet Gynecol"},{"issue":"suppl 1","key":"R104-20261111","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1093\/jpids\/piu064","article-title":"Prevention of perinatal hepatitis B virus transmission","volume":"3","author":"Nelson","year":"2014","journal-title":"J Pediatr Infect Dis Soc"},{"key":"R105-20261111","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.15585\/mmwr.mm7348a3","article-title":"Updated recommendation for universal hepatitis B vaccination in adults aged 19-59 years\u2014United States, 2024","volume":"73","author":"Sandul","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R106-20261111","doi-asserted-by":"crossref","first-page":"477","DOI":"10.15585\/mmwr.mm7113a1","article-title":"Universal hepatitis B vaccination in adults aged 19-59 years: updated Recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2022","volume":"71","author":"Weng","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R107-20261111","doi-asserted-by":"crossref","first-page":"455","DOI":"10.15585\/mmwr.mm6715a5","article-title":"Recommendations of the Advisory Committee on Immunization Practices for use of a hepatitis B vaccine with a novel adjuvant","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R108-20261111","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.idc.2015.07.003","article-title":"The challenge of global poliomyelitis eradication","volume":"29","author":"Garon","year":"2015","journal-title":"Infect Dis Clin North Am"},{"key":"R109-20261111","first-page":"1","article-title":"Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"49","author":"Prevots","year":"2000","journal-title":"MMWR Recomm Rep"},{"key":"R110-20261111","first-page":"1","article-title":"Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Staples","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"R111-20261111","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0035-9203(93)90156-K","article-title":"Yellow fever vaccination and pregnancy: a four-year prospective study","volume":"87","author":"Nasidi","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R112-20261111","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1365-3156.1998.00164.x","article-title":"Yellow fever vaccination during pregnancy and spontaneous abortion: a case-control study","volume":"3","author":"Nishioka","year":"1998","journal-title":"Trop Med Int Health"},{"key":"R113-20261111","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1365-3156.2007.01851.x","article-title":"Early exposure to yellow fever vaccine during pregnancy","volume":"12","author":"Cavalcanti","year":"2007","journal-title":"Trop Med Int Health"},{"key":"R114-20261111","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.vaccine.2005.09.033","article-title":"The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil","volume":"24","author":"Suzano","year":"2006","journal-title":"Vaccine"},{"key":"R115-20261111","doi-asserted-by":"crossref","first-page":"taaa138","DOI":"10.1093\/jtm\/taaa138","volume":"27","author":"Hall","year":"2020","journal-title":"J Travel Med"},{"key":"R116-20261111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6802a1","article-title":"Japanese encephalitis vaccine: recommendations of the Advisory Committee on Immunization Practices","volume":"68","author":"Hills","year":"2019","journal-title":"MMWR Recomm Rep"},{"key":"R117-20261111","first-page":"1","article-title":"Human rabies prevention\u2014United States, 2008: recommendations of the Advisory Committee on Immunization Practices","volume":"57","author":"Manning","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"R118-20261111","doi-asserted-by":"crossref","first-page":"E1281","DOI":"10.1503\/cmaj.180727","article-title":"Exposure to rabies during pregnancy","volume":"190","author":"Windrim","year":"2018","journal-title":"CMAJ"},{"key":"R119-20261111","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/AOG.0b013e318270ec08","article-title":"Anthrax cases in pregnant and postpartum women: a systematic review","volume":"120","author":"Meaney-Delman","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R120-20261111","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/aje\/kwn159","article-title":"Birth defects among infants born to women who received anthrax vaccine in pregnancy","volume":"168","author":"Ryan","year":"2008","journal-title":"Am J Epidemiol"},{"key":"R121-20261111","doi-asserted-by":"crossref","first-page":"e130611","DOI":"10.3201\/eid2002.130611","article-title":"Special considerations for prophylaxis for and treatment of anthrax in pregnant and postpartum women","volume":"20","author":"Meaney-Delman","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"R122-20261111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6804a1","article-title":"Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices, 2019","volume":"68","author":"Bower","year":"2019","journal-title":"MMWR Recomm Rep"},{"key":"R123-20261111","first-page":"1","article-title":"Clinical guidance for smallpox vaccine use in a postevent vaccination program","volume":"64","author":"Petersen","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"R124-20261111","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1001\/jama.2024.21091","article-title":"Mpox clinical presentation, diagnostic approaches, and treatment strategies: a review","volume":"332","author":"Titanji","year":"2024","journal-title":"JAMA"},{"key":"R125-20261111","doi-asserted-by":"crossref","first-page":"EVIDpha2500319","DOI":"10.1056\/EVIDpha2500319","article-title":"Detection of community transmission of clade Ib mpox virus in the United States","volume":"5","author":"Tang","year":"2026","journal-title":"NEJM Evid"},{"key":"R129-20261111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14760584.2025.2543809","article-title":"Hepatitis E vaccine landscape update 2025","volume":"24","author":"Kim","year":"2025","journal-title":"Expert Rev Vaccin"},{"key":"R130-20261111","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.vaccine.2018.12.025","article-title":"Malaria vaccine trials in pregnant women: an imperative without precedent","volume":"37","author":"Healy","year":"2019","journal-title":"Vaccine"},{"key":"R132-20261111","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0140-6736(25)00345-9","article-title":"Chikungunya virus virus-like particle vaccine safety and immunogenicity in adolescents and adults in the USA: a phase 3, randomised, double-blind, placebo-controlled trial","volume":"405","author":"Richardson","year":"2025","journal-title":"Lancet"},{"key":"R133-20261111","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.3390\/jcm14113986","article-title":"Congenital Rubella syndrome in the post-elimination era: why vigilance remains essential","volume":"14","author":"De Melo","year":"2025","journal-title":"J Clin Med"},{"key":"R134-20261111","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1097\/01.AOG.0000466430.19823.53","article-title":"Cytomegalovirus, parvovirus B19, varicella zoster, and toxoplasmosis in pregnancy. Practice Bulletin No. 151. American College of Obstetricians and Gynecologists","volume":"125","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R135-20261111","first-page":"1","article-title":"Control and prevention of rubella: evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome","volume":"50","year":"2001","journal-title":"MMWR Recomm Rep"},{"key":"R136-20261111","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"R137-20261111","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.vaccine.2019.11.070","article-title":"Safety profile of rubella vaccine administered to pregnant women: a systematic review of pregnancy related adverse events following immunisation, including congenital rubella syndrome and congenital rubella infection in the foetus or infant","volume":"38","author":"Mangtani","year":"2020","journal-title":"Vaccine"},{"issue":"suppl 4","key":"R138-20261111","doi-asserted-by":"crossref","first-page":"S441","DOI":"10.1093\/infdis\/jiac277","article-title":"Merck\/Centers for Disease Control and Prevention varicella vaccine pregnancy registry: 19-year summary of data from inception through closure, 1995-2013","volume":"226","author":"Willis","year":"2022","journal-title":"J Infect Dis"},{"key":"R139-20261111","first-page":"1","article-title":"Prevention of perinatal group B streptococcal disease\u2014revised guidelines from CDC, 2010","volume":"59","author":"Verani","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"suppl 4","key":"R140-20261111","doi-asserted-by":"crossref","first-page":"D46","DOI":"10.1016\/j.vaccine.2012.11.026","article-title":"Group B Streptococcus vaccination in pregnancy: moving toward a global maternal immunization program","volume":"31","author":"Munoz","year":"2013","journal-title":"Vaccine"},{"key":"R141-20261111","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/AOG.0000000000001190","article-title":"Maternal immunization with an Investigational Trivalent Group B streptococcal vaccine: a randomized controlled trial","volume":"127","author":"Donders","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R142-20261111","doi-asserted-by":"crossref","first-page":"e807","DOI":"10.1016\/S2214-109X(22)00093-6","article-title":"Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden","volume":"10","author":"Goncalves","year":"2022","journal-title":"Lancet Glob Health"},{"key":"R143-20261111","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1093\/cid\/cix664","article-title":"Estimates of the Burden of Group B streptococcal disease worldwide for pregnant women, stillbirths, and children","volume":"65","author":"Seale","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R144-20261111","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.1016\/j.vaccine.2017.09.087","article-title":"Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics","volume":"37","author":"Vekemans","year":"2019","journal-title":"Vaccine"},{"key":"R145-20261111","doi-asserted-by":"crossref","first-page":"2330138","DOI":"10.1080\/21645515.2024.2330138","article-title":"Interlaboratory comparison of a multiplex immunoassay that measures human serum IgG antibodies against six-group B streptococcus polysaccharides","volume":"20","author":"Le Doare","year":"2024","journal-title":"Hum Vaccin Immunother"},{"key":"R146-20261111","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/cid\/cix666","article-title":"Antibody kinetics and response to routine vaccinations in infants born to women who received an Investigational Trivalent Group B streptococcus polysaccharide CRM197-Conjugate vaccine during pregnancy","volume":"65","author":"Madhi","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R147-20261111","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S1473-3099(16)00152-3","article-title":"Safety and immunogenicity of an Investigational Maternal Trivalent Group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b\/2 trial","volume":"16","author":"Madhi","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"R148-20261111","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S1473-3099(15)00484-3","article-title":"Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial","volume":"16","author":"Heyderman","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"R149-20261111","doi-asserted-by":"crossref","first-page":"6696","DOI":"10.1128\/IAI.69.11.6696-6701.2001","article-title":"Effects of alum adjuvant or a booster dose on immunogenicity during clinical trials of group B streptococcal type III conjugate vaccines","volume":"69","author":"Paoletti","year":"2001","journal-title":"Infect Immun"},{"key":"R150-20261111","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1016\/S0264-410X(03)00353-0","article-title":"Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine","volume":"21","author":"Baker","year":"2003","journal-title":"Vaccine"},{"key":"R151-20261111","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa2116045","article-title":"Potential for maternally Administered Vaccine for Infant Group B streptococcus","volume":"389","author":"Madhi","year":"2023","journal-title":"N Engl J Med"},{"key":"R152-20261111","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1473-3099(20)30478-3","article-title":"Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1\/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial","volume":"21","author":"Absalon","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"R153-20261111","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1016\/j.vaccine.2021.06.046","article-title":"Safety and immunogenicity of a prototype recombinant alpha-like protein subunit vaccine (GBS-NN) against Group B Streptococcus in a randomised placebo-controlled double-blind phase 1 trial in healthy adult women","volume":"39","author":"Fischer","year":"2021","journal-title":"Vaccine"},{"key":"R154-20261111","doi-asserted-by":"crossref","first-page":"106261","DOI":"10.1016\/j.isci.2023.106261","article-title":"Safety and immunogenicity of the group B streptococcus vaccine AlpN in a placebo-controlled double-blind phase 1 trial","volume":"26","author":"Gonzalez-Miro","year":"2023","journal-title":"iScience"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006243","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:00:44Z","timestamp":1794430844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":144,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000006243","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"2025-11-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}